An outbreak of typhoid fever, Xing-An County, People's Republic of China, 1999: Estimation of the field effectiveness of Vi polysaccharide typhoid vaccine

Journal of Infectious Diseases

Volumn 183, Issue 12, 2001, Pages 1775-1780

  Yang, Hong Hui ^a   Kilgore, Paul E ^d   Yang, Ling Hong ^b   Park, Jin Kyung ^e   Pan, You Fu ^c   Kim, Yongdai ^e   Lee, Young Jack ^d,f   Xu, Zhi Yi ^d   Clemens, John D ^d  

^a Guangxi Health and Anti Epidemic Center   (China)

^b Xing An County Middle School   (China)

^c Guangxi Zhuang Autonomous Region   (China)

^d International Vaccine Institute   (South Korea)

^e Hankuk University of Foreign Studies   (South Korea)

^f Hanyang University   (South Korea)

Author keywords

[No Author keywords available]

Indexed keywords

TYPHOID VACCINE;

ADOLESCENT; ARTICLE; CHILD; CHINA; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE ASSOCIATION; DISEASE CONTROL; DRUG EFFECT; ENDEMIC DISEASE; FEMALE; HUMAN; IMMUNIZATION; INFECTION CONTROL; MALE; PREVALENCE; PRIORITY JOURNAL; PROPHYLAXIS; PUBLIC HEALTH; TYPHOID FEVER; VACCINATION;

ADOLESCENT; ADULT; CHILD; CHINA; DISEASE OUTBREAKS; FEMALE; HUMANS; MALE; POLYSACCHARIDES, BACTERIAL; PROPORTIONAL HAZARDS MODELS; SALMONELLA TYPHI; TIME FACTORS; TREATMENT OUTCOME; TYPHOID FEVER; TYPHOID-PARATYPHOID VACCINES; VACCINATION;

EID: 0035877044     PISSN: 00221899     EISSN: None     Source Type: Journal    
DOI: 10.1086/320729     Document Type: Article

References (41)

1. Vaccination against typhoid fever: Present status
2. Typhoid fever: Important issues still remain
3. Typhoid fever in children aged less than 5 years
4. Epidemic typhoid in Vietnam: Molecular typing of multiple-antibiotic- resistant Salmonella enterica serotype typhi from four outbreaks
5. Multidrug-resistant Salmonella typhi: A worldwide epidemic
6. Water-borne transmission of chloramphenicol-resistant Salmonella typhi in Mexico
7. The antimicrobial resistance of S. typhi and an outbreak of typhoid fever
8. A comparative study of ofloxacin and cefixime for treatment of typhoid fever in children: The Dong Nai Pediatric Center Typhoid Study Group
9. A highly ceftriaxone-resistant Salmonella typhi in Bangladesh
10. Therapy of multidrug-resistant typhoid fever with oral cefixime vs. intravenous ceftriaxone
11. Laboratory and preliminary clinical characterization of Vi capsular polysaccharide-protein conjugate vaccines
12. Safety and immunogenicity of Vi conjugate vaccines for typhoid fever in adults, teenagers, and 2- to 4-year-old children in Vietnam
13. Protective efficacy and immunogenicity of Vi-porin conjugate against Salmonella typhi
14. Prevention of typhoid fever in Nepal with the Vi capsular polysaccharide of Salmonella typhi: A preliminary report
15. Immunogenicity, efficacy and serological correlate of protection of Salmonella typhi Vi capsular polysaccharide vaccine three years after immunization
16. Efficacy and side effects following immunization with Salmonella typhi Vi capsular polysaccharide vaccine
17. Efficacy trial of Vi polysaccharide vaccine against typhoid fever in southwestern China
18. Usefulness of the Widal test in diagnosing childhood typhoid fever in endemic areas
19. Value of a single-tube widal test in diagnosis of typhoid fever in Vietnam
20. The value of a single Widal test in the diagnosis of acute typhoid fever
21. Estimation of a common effect parameter from sparse follow-up data
22. The Cox proportional hazards model with change point: An epidemiologic application
23. Protective activity of Vi capsular polysaccharide vaccine against typhoid fever
24. Rapid serologic diagnosis of pediatric typhoid fever in an endemic area: A prospective comparative evaluation of two dot-enzyme immunoassays and the Widal test
25. Significance and value of the Widal test in the diagnosis of typhoid fever in an endemic area
26. Side effects and seroconversion following immunization with typhoid Vi polysaccharide
27. Considerations regarding mass vaccination against typhoid fever as an adjunct to sanitation and public health measures
28. Large-scale field trial of Ty21a live oral typhoid vaccine in enteric-coated capsule formulation
29. Comparative efficacy of two, three, or four doses of TY21a live oral typhoid vaccine in enteric-coated capsules: A field trial in an endemic area
30. Efficacy of one or two doses of Ty21a Salmonella typhi vaccine in enteric-coated capsules in a controlled field trial: Chilean Typhoid Committee
31. Oral immunisation against typhoid fever in Indonesia with Ty21a vaccine
32. Epidemiology and control of an outbreak of typhoid in a psychiatric institution
33. Control of typhoid fever in Bangkok, Thailand, by annual immunization of schoolchildren with parenteral typhoid vaccine
34. Multidrug resistant Salmonella typhi in Bangalore, south India
35. Molecular epidemiology of antibiotic resistance genes in multiresistant epidemic Salmonella typhimurium DT 104
36. Laboratory-based surveillance of Salmonella serotype typhi infections in the United States: Antimicrobial resistance on the rise
37. Chloramphenicol-resistant S typhimurium
38. Multi-drug-resistant Salmonella typhi: A need for therapeutic reappraisal
39. Resistance to ciprofloxacin in pathogenic Enterobacteriaceae in England and Wales in 1996
40. Ciprofloxacin-resistant Salmonella typhi and treatment failure